Should You Invest in the VanEck Pharmaceutical ETF (PPH)?

11:20am, Tuesday, 21'st Feb 2023 Zacks Investment Research
Sector ETF report for PPH
RAHWAY, N.J.--(BUSINESS WIRE)---- $MRK #MRK--Merck to Present New Data for Sotatercept and MK-0616 at ACC.

Is Most-Watched Stock Merck & Co., Inc. (MRK) Worth Betting on Now?

02:00pm, Monday, 20'th Feb 2023 Zacks Investment Research
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Merck (MRK) Gets Priority Tag for Antiviral Drug Prevymis sNDA

01:38pm, Monday, 20'th Feb 2023 Zacks Investment Research
The FDA grants priority review designation to Merck's (MRK) sNDA seeking expanded use of Prevymis. The PDUFA date is Jun 5, 2023.
Zacks.com users have recently been watching Merck (MRK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
The FDA grants priority review designation to Merck's (MRK) sNDA seeking expanded use of Prevymis. The PDUFA date is Jun 5, 2023.
Two new Breakout Stocks for Week 8 with better than 10% short-term upside and two Dow 30 Picks. Average cumulative returns for 2023 are +36.7% YTD. This week peak gains were in INDI +22.83% and LTRX +
Despite the sharp slide in biotech stocks during 2022, the industry is still poised for mega growth.  Pandemic preparedness needs better vaccines and disease detection methods.

Should Income Investors Buy This Dow Jones Stock?

02:15pm, Friday, 17'th Feb 2023 The Motley Fool
This drugmaker boasts an impressive product portfolio and pipeline.
This drugmaker boasts an impressive product portfolio and pipeline.

Why Shares of Organon Fell 15% Thursday

11:12pm, Thursday, 16'th Feb 2023 The Motley Fool
The company reported fourth-quarter and year-end financials.
Is Merck stock a buy or a sell after Keytruda succeeded in one study but failed in another in late January? Is MRK stock a buy or a sell?

2 Ultra-Safe Dividend Stocks to Buy Right Now

03:15pm, Thursday, 16'th Feb 2023 The Motley Fool
These two dividend stocks are top buys for investors concerned about an economic slowdown.

Moderna (MRNA) to Report Q4 Earnings: What's in the Cards?

03:10pm, Thursday, 16'th Feb 2023 Zacks Investment Research
Investors focus will likely be on Moderna's (MRNA) pipeline, especially with its late-stage pipeline candidates, when it reports fourth-quarter earnings.

Seagen's (SGEN) Q4 Earnings & Sales Beat Estimates, Stock Up

02:34pm, Thursday, 16'th Feb 2023 Zacks Investment Research
Seagen (SGEN) reports better-than-expected results in the fourth quarter of 2022, beating both earnings and sales estimates. Stock up in the after-market hours in response to the news.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE